Hemogenyx Pharmaceuticals (LSE:HEMO) Price-to-Operating-Cash-Flow : (As of May. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-21), Hemogenyx Pharmaceuticals's share price is £0.01515. Hemogenyx Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01. Hence, Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:HEMO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.93
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Hemogenyx Pharmaceuticals's Cash Flow from Operations per share for the six months ended in Dec. 2023 was £-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.40% per year.

During the past 9 years, Hemogenyx Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 9.10% per year. The lowest was -26.00% per year. And the median was 0.70% per year.

Hemogenyx Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Hemogenyx Pharmaceuticals Annual Data

Trend

Feb15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Hemogenyx Pharmaceuticals Semi-Annual Data
	Feb15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Hemogenyx Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.01515	/	-0.005
	=

Hemogenyx Pharmaceuticals's Share Price of today is £0.01515.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hemogenyx Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Hemogenyx Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hemogenyx Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemogenyx Pharmaceuticals (LSE:HEMO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

5HU:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.hemogenyx.com

Hemogenyx Pharmaceuticals PLC is a operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation / Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.

Hemogenyx Pharmaceuticals (LSE:HEMO) Headlines

No Headlines